Patents by Inventor Crilles Casper Larsen

Crilles Casper Larsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190351060
    Abstract: Described herein are pharmaceutical rectal foam formulations, useful, for example, for the rectal administration of therapeutic agents, such as 5-aminosalicylic acid (5-ASA), as well as methods of making such foam formulations, and therapeutic methods using them.
    Type: Application
    Filed: December 14, 2017
    Publication date: November 21, 2019
    Applicant: FERRING B.V.
    Inventor: Crilles Casper Larsen
  • Publication number: 20170049758
    Abstract: Liquid formulations containing picosulfate and magnesium citrate are provided. The formulations are useful to treat constipation or for the clearance of the bowel prior to X-ray examination, endoscopy or surgery.
    Type: Application
    Filed: August 16, 2016
    Publication date: February 23, 2017
    Inventors: Alfred Chi-Yeh Liang, Nipul Ghanshyambhai Patel, Jian-Xin Li, Crilles Casper Larsen
  • Patent number: 9114083
    Abstract: Disclosed are improved granular pharmaceutical preparations, together with improved methods and apparatus for preparation of granules for use in such preparations. Such methods are especially useful for making granules for solid oral dose pharmaceutical preparations, and are particularly suited to the production of granules comprising 5-aminosalicylic acid (5-ASA) for the treatment of inflammatory bowel disease. The granules exhibit a more sharply peaked length distribution, and hence aspect ratio distribution, and have a consequently much sharper dissolution profile after further processing.
    Type: Grant
    Filed: May 16, 2014
    Date of Patent: August 25, 2015
    Assignee: FERRING B.V.
    Inventors: Carsten Hoeg-Moller, Crilles Casper Larsen, Jorgen Wittendorff, Birgitte Nissen, Kenneth Manby Pedersen, Tue Hansen, Helle Poulsen
  • Publication number: 20140328934
    Abstract: Disclosed are improved granular pharmaceutical preparations, together with improved methods and apparatus for preparation of granules for use in such preparations. Such methods are especially useful for making granules for solid oral dose pharmaceutical preparations, and are particularly suited to the production of granules comprising 5-aminosalicylic acid (5-ASA) for the treatment of inflammatory bowel disease. The granules exhibit a more sharply peaked length distribution, and hence aspect ratio distribution, and have a consequently much sharper dissolution profile after further processing.
    Type: Application
    Filed: May 16, 2014
    Publication date: November 6, 2014
    Applicant: Ferring B.V.
    Inventors: Carsten Hoeg-Moller, Crilles Casper Larsen, Jorgen Wittendorff, Birgitte Nissen, Kenneth Manby Pedersen, Tue Hansen, Helle Poulsen
  • Patent number: 8765185
    Abstract: Disclosed are improved granular pharmaceutical preparations, together with improved methods and apparatus for preparation of granules for use in such preparations. Such methods are especially useful for making granules for solid oral dose pharmaceutical preparations, and are particularly suited to the production of granules comprising 5-aminosalicylic acid (5-ASA) for the treatment of inflammatory bowel disease. The granules exhibit a more sharply peaked length distribution, and hence aspect ratio distribution, and have a consequently much sharper dissolution profile after further processing.
    Type: Grant
    Filed: December 15, 2010
    Date of Patent: July 1, 2014
    Assignee: Ferring B.V.
    Inventors: Carsten Hoeg-Moller, Crilles Casper Larsen, Jorgen Wittendorff, Birgitte Nissen, Kenneth Manby Pedersen, Tue Hansen, Helle Poulsen
  • Publication number: 20130022681
    Abstract: Disclosed are improved granular pharmaceutical preparations, together with improved methods and apparatus for preparation of granules for use in such preparations. Such methods are especially useful for making granules for solid oral dose pharmaceutical preparations, and are particularly suited to the production of granules comprising 5-aminosalicylic acid (5-ASA) for the treatment of inflammatory bowel disease. The granules exhibit a more sharply peaked length distribution, and hence aspect ratio distribution, and have a consequently much sharper dissolution profile after further processing.
    Type: Application
    Filed: December 15, 2010
    Publication date: January 24, 2013
    Applicant: Ferring B.V.
    Inventors: Carsten Hoeg-Moller, Crilles Casper Larsen, Jorgen Wittendorff, Birgitte Nissen, Kenneth Manby Pedersen, Tue Hansen, Helle Poulsen